Le Lézard
Classified in: Environment, Health, Science and technology
Subject: Product/Service

Packaging Technology Group (PTG) Completes Its Line of Thermally Pre-Qualified 2-8°C Shipping Solutions for Vaccines and Biologics


Packaging Technology Group, Inc (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and life sciences sector, responds to the global pandemic with the launch of its off-the-shelf line of pre-qualified shippers, including an earth-friendly alternative.

As pharmaceutical manufacturers race to respond to the global health crisis with a vaccine, the need to protect any potential vaccine's temperature tolerance remains a priority. According to the WHO (World Health Organization), up to 50% of vaccines are wasted each year, often due to inadequate temperature control in supply chain.

Packaging Technology Group has spent the last 15+ years protecting life-saving medications by designing, engineering, and manufacturing thermal packaging solutions for the world's leading pharmaceutical companies. PTG's engineering team has worked tirelessly to ensure qualified options will be available when it comes time to distribute the vaccine to 8 billion people around the globe, safely.

"Most vaccines require a 2-8°C temperature range, and others could be -80°C. It is essential that any vaccine maintains its required temperature throughout the supply chain," said Bill Blezard, Chief Executive Officer of PTG. "We are committed to developing packaging designed to improve and simplify shipping solutions for critical temperature-sensitive pharmaceuticals and biologics."

The new off-the-shelf line pre-qualified solutions include small, medium, and large shippers that all maintain a temperature profile of 2-8°C for 48-96 hours. Each shipper has a qualified design to perform in the summer and winter seasons. This new line offers clients ease of ordering and will be a superior choice when selecting a supportive thermal shipper for vaccines and new biologics.

The pre-qualified solutions are offered in four different insulating materials, including EPS (expanded polystyrene), Cellulose, VIP (vacuum insulated panels), and PUR (polyurethane). The shippers in the cellulose line are 100% curbside recyclable and certified re-pulpable, which means the entire box can be conveniently disposed of in a standard recycling bin. To date, PTG has saved ~400,000 pounds of EPS from landfills by offering this earth-friendly solution.

ABOUT PTG: PTG designs, engineers, and manufactures sustainable, thermal shipping and packaging solutions for the biopharmaceutical and life sciences sector. Established in 2005 as a faith-based organization, PTG remains privately held by its founder, ensuring an active and vibrant culture steeped in the company's foundational principles, traditions, and values. Headquartered in Fall River, Massachusetts, the company maintains a strong commitment to the community.

For more information on PTG's line of pre-qualified solutions, contact Kelly Cinelli, Director of Marketing at [email protected].


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: